All In MedTech

Device type · JLS

Radioimmunoassay, Progesterone

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about JLS: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

JLS

Clinical Chemistry

Device class

Class I

FDA decisions since 2015

0

510(k), De Novo and PMA

Adverse event reports

14

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Radioimmunoassay, Progesterone
Product code
JLS
Device class
Class I
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1620

Latest FDA decisions

All decisions for JLS

No 510(k), De Novo or PMA decisions for this product code since 2015.

Reports received

14

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

10

71% of reports

Injury reports

4

29% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231000
Jan 240000
Feb 243000
Mar 240000
Apr 240000
May 241000
Jun 241000
Jul 242000
Aug 240000
Sep 240000
Oct 240000
Nov 240000
Dec 240000
Jan 250000
Feb 250000
Mar 250000
Apr 250100
May 250000
Jun 250000
Jul 250000
Aug 250000
Sep 250000
Oct 250000
Nov 250200
Dec 250000
Jan 267000
Feb 260100
Mar 260000
Apr 260000
May 260000
Jun 261000
Jul 261000
Aug 260000
Sep 261000
Oct 260100
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • High Test Results7
  • Incorrect, Inadequate or Imprecise Result or Readings7

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions11
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available3

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Biomerieux Inc

    Z-0866-2023 · Started Nov 9, 2022 · Posted by FDA Jan 4, 2023

    Reason given: As the temperature and time out of range was exceeded, product performances cannot be guaranteed

    Cause as FDA categorized it: Storage

  • bioMerieux, Inc.

    Z-0424-2022 · Started Sep 22, 2021

    Reason given: bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.

    Cause as FDA categorized it: Nonconforming Material/Component

  • Siemens Healthcare Diagnostics, Inc.

    Z-2289-2019 · Started Jul 10, 2019 · Posted by FDA Aug 17, 2019

    Reason given: There is a potential for low discordant progesterone results on a subset of patient samples. A falsely low progesterone result may lead to the consideration for additional progesterone supplementation.

    Cause as FDA categorized it: Under Investigation by firm

18 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.